Determinants of Improved Dyspnea and Exercise Tolerance With Nasal High-Flow O(2) Therapy in Fibrotic Interstitial Lung Disease: A Pilot Physiological Study.

Thivent S, Ginoux M, Verges S, Hérengt F, Marillier M

Open source

DOI
10.1002/resp.70251
Published
2026 Jul
Container
Respirology (Carlton, Vic.)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/resp.70251,
  title = {Determinants of Improved Dyspnea and Exercise Tolerance With Nasal High-Flow O(2) Therapy in Fibrotic Interstitial Lung Disease: A Pilot Physiological Study.},
  author = {Thivent S and Ginoux M and Verges S and Hérengt F and Marillier M},
  year = {2026},
  journal = {Respirology (Carlton, Vic.)},
  doi = {10.1002/resp.70251},
  url = {https://doi.org/10.1002/resp.70251}
}

RIS

TY  - JOUR
TI  - Determinants of Improved Dyspnea and Exercise Tolerance With Nasal High-Flow O(2) Therapy in Fibrotic Interstitial Lung Disease: A Pilot Physiological Study.
AU  - Thivent S
AU  - Ginoux M
AU  - Verges S
AU  - Hérengt F
AU  - Marillier M
PY  - 2026
JO  - Respirology (Carlton, Vic.)
DO  - 10.1002/resp.70251
UR  - https://doi.org/10.1002/resp.70251
ER  - 

APA

S, T., M, G., S, V., F, H., & M, M. (2026). Determinants of Improved Dyspnea and Exercise Tolerance With Nasal High-Flow O(2) Therapy in Fibrotic Interstitial Lung Disease: A Pilot Physiological Study.. Respirology (Carlton, Vic.). https://doi.org/10.1002/resp.70251

Source records